跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 67,055 条关于
“RPTR-1-201”
全部
67,055
临床试验
38,503
药物
11,498
机构
1,395
资讯
15,659
4个月前
Repertoire Immune Medicines Initiates First-in-Human Trial of Novel TCR Bispecific Therapy for Advanced Solid Tumors
去年
Repertoire Immune Medicines Appoints Oncology Veteran as CMO, Advances TCR Bispecific Toward Phase 1/2 Trial
2年前
NXC-201 CAR T-cell Therapy Shows Promise in AL Amyloidosis Despite Mortality Concerns
5个月前
Absci's AI-Designed Hair Loss Treatment ABS-201 Shows Promising Safety Data in Phase 1/2a Trial
去年
Creative Medical's CELZ-201-DDT Shows Promising Safety Profile in Phase 1/2 Degenerative Disc Disease Trial
去年
QurAlis Advances ALS Programs: QRL-201 Enters Dose Range-Finding, QRL-101 Dosed in Phase 1
去年
Aptamer Sciences' Liver Cancer Drug, AST-201, Enters Phase 1 Trials in Korea
7个月前
Affinia Therapeutics Receives FDA Clearance to Begin Phase 1/2 Trial of AFTX-201 Gene Therapy for Rare Heart Disease
上个月
Pacira's Gene Therapy PCRX-201 Shows Durable Two-Year Benefit in Knee Osteoarthritis, Phase 1 Data Published in Annals of the Rheumatic Diseases
3年前
Nexcella's NXC-201 Shows Promise in Relapsed/Refractory Multiple Myeloma and AL Amyloidosis
第 1 页,共 1566 页
上一页
下一页